BiologyWorks is the developer of the BiologyWorks k(now) test, a fast molecular test for qualitative detection of pathogens and molecular biomarkers for SARS-CoV-2 and other viruses and infections.
The ISO 13485:2016 certification is granted when organizations that offer medical devices and related services have quality management systems that consistently meet customer and applicable regulatory requirements. ISO (International Organization for Standardization) is an independent, non-governmental international organization that supports innovation and the development of solutions to global issues through its standardized guidelines.
This certification adds to BiologyWorks' existing CE IVD European Council Directive 98/79/EC certification for manufacturers of in vitro diagnostic medical devices in the European Union.
The BiologyWorks k(now) test is a small handheld and affordable device that delivers highly accurate results about infections or diseases with a recognizable gene sequence, including COVID-19.
According to the company, the device is easy to use, ultra-portable, safeguards patient data and eliminates the need for a diagnostic laboratory, providing fast, real-time results in less than 30 minutes.
BiologyWorks' chemistry is patent-protected and based on years of research originating with the Alfred Mann Foundation and is supported by a grant from the Bill and Melinda Gates Foundation.
The BiologyWorks k(now) test has received a CE Mark and is available for point-of-care sale in Europe and many parts of the world.
BiologyWorks is the creator of BiologyWorks k(now), usable for quickly identifying COVID-19 infections with an accuracy akin to PCR. The BiologyWorks k(now) test is an affordable small, handheld device and sample kit using a nasal swab.
The patented molecular testing technologies are effective in a multitude of use cases ranging from infections and diseases to environmental contaminations.
TELA Bio launches LIQUIFIX for US hernia surgery
Cognizant and NVIDIA partner to revolutionize drug discovery with generative AI
Neupulse raises funds for Tourettes Syndrome wearable tech
Bonesupport gains FDA clearance for CERAMENT G in open fractures
Epitomee submits Weight Loss Capsule for FDA approval in US
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon